Research and analysis

Comparative performance of SARS CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimens, 11 March 2021

Paper prepared by academics on the sensitivity of lateral flow antigen tests.

• From: Scientific Advisory Group for Emergencies
• Published: 30 June 2021
• Last updated: 20 August 2021 — See all updates

Documents

Comparative performance of SARS CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimens, 11 March 2021

PDF, 307 KB, 20 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Supporting paper prepared by academics on lateral flow devices. This paper was available for participants to read at SAGE 83 on 11 March 2021, but not considered or discussed in the meeting.

The paper is the assessment of the evidence at the time of writing. As new evidence or data emerges, SAGE updates its advice accordingly.

This paper was first published on the Lancet website on 30 June 2021.

These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.

Published 30 June 2021
Last updated 20 August 2021 + show all updates

1. 20 August 2021

   This paper was released as part of a batch of SAGE documents on 20 August 2021.

2. 30 June 2021

   First published.